UniProt ID | CBX5_HUMAN | |
---|---|---|
UniProt AC | P45973 | |
Protein Name | Chromobox protein homolog 5 | |
Gene Name | CBX5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 191 | |
Subcellular Localization | Nucleus . Chromosome . Chromosome, centromere . Colocalizes with HNRNPU in the nucleus (PubMed:19617346). Component of centromeric and pericentromeric heterochromatin. Associates with chromosomes during mitosis. Associates specifically with chromatin | |
Protein Description | Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph). Can interact with lamin-B receptor (LBR). This interaction can contribute to the association of the heterochromatin with the inner nuclear membrane. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins.. | |
Protein Sequence | MGKKTKRTADSSSSEDEEEYVVEKVLDRRVVKGQVEYLLKWKGFSEEHNTWEPEKNLDCPELISEFMKKYKKMKEGENNKPREKSESNKRKSNFSNSADDIKSKKKREQSNDIARGFERGLEPEKIIGATDSCGDLMFLMKWKDTDEADLVLAKEANVKCPQIVIAFYEERLTWHAYPEDAENKEKETAKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MGKKTKRTADSS ---CCCCCCCCCCCC | 29.28 | 25072903 | |
8 | Phosphorylation | MGKKTKRTADSSSSE CCCCCCCCCCCCCCC | 36.05 | 22167270 | |
11 | Phosphorylation | KTKRTADSSSSEDEE CCCCCCCCCCCCCHH | 29.65 | 22167270 | |
12 | Phosphorylation | TKRTADSSSSEDEEE CCCCCCCCCCCCHHH | 38.13 | 22167270 | |
13 | Phosphorylation | KRTADSSSSEDEEEY CCCCCCCCCCCHHHH | 41.52 | 22167270 | |
14 | Phosphorylation | RTADSSSSEDEEEYV CCCCCCCCCCHHHHH | 51.52 | 22167270 | |
20 | Phosphorylation | SSEDEEEYVVEKVLD CCCCHHHHHHHHHHH | 17.05 | 22167270 | |
32 | Malonylation | VLDRRVVKGQVEYLL HHHHHHHHHHHHHHH | 40.54 | 26320211 | |
32 | Methylation | VLDRRVVKGQVEYLL HHHHHHHHHHHHHHH | 40.54 | - | |
32 | Ubiquitination | VLDRRVVKGQVEYLL HHHHHHHHHHHHHHH | 40.54 | 21890473 | |
32 | Sumoylation | VLDRRVVKGQVEYLL HHHHHHHHHHHHHHH | 40.54 | - | |
32 | Sumoylation | VLDRRVVKGQVEYLL HHHHHHHHHHHHHHH | 40.54 | 28112733 | |
32 | 2-Hydroxyisobutyrylation | VLDRRVVKGQVEYLL HHHHHHHHHHHHHHH | 40.54 | - | |
37 | Phosphorylation | VVKGQVEYLLKWKGF HHHHHHHHHHHCCCC | 20.62 | 29759185 | |
40 | Acetylation | GQVEYLLKWKGFSEE HHHHHHHHCCCCCCH | 44.24 | 26051181 | |
40 | Ubiquitination | GQVEYLLKWKGFSEE HHHHHHHHCCCCCCH | 44.24 | 21890473 | |
40 | Methylation | GQVEYLLKWKGFSEE HHHHHHHHCCCCCCH | 44.24 | - | |
42 | Ubiquitination | VEYLLKWKGFSEEHN HHHHHHCCCCCCHHC | 48.79 | - | |
42 | Acetylation | VEYLLKWKGFSEEHN HHHHHHCCCCCCHHC | 48.79 | 26051181 | |
45 | Phosphorylation | LLKWKGFSEEHNTWE HHHCCCCCCHHCCCC | 51.23 | 25159151 | |
55 | Ubiquitination | HNTWEPEKNLDCPEL HCCCCCCCCCCHHHH | 73.80 | - | |
55 | Acetylation | HNTWEPEKNLDCPEL HCCCCCCCCCCHHHH | 73.80 | 26051181 | |
59 | Glutathionylation | EPEKNLDCPELISEF CCCCCCCHHHHHHHH | 2.96 | 22555962 | |
68 | Acetylation | ELISEFMKKYKKMKE HHHHHHHHHHHHHHC | 59.27 | 25953088 | |
68 | Ubiquitination | ELISEFMKKYKKMKE HHHHHHHHHHHHHHC | 59.27 | - | |
69 | Ubiquitination | LISEFMKKYKKMKEG HHHHHHHHHHHHHCC | 50.98 | - | |
69 | Sumoylation | LISEFMKKYKKMKEG HHHHHHHHHHHHHCC | 50.98 | - | |
71 | Sumoylation | SEFMKKYKKMKEGEN HHHHHHHHHHHCCCC | 56.10 | - | |
74 | 2-Hydroxyisobutyrylation | MKKYKKMKEGENNKP HHHHHHHHCCCCCCC | 72.02 | - | |
80 | Acetylation | MKEGENNKPREKSES HHCCCCCCCCCHHHH | 57.97 | 26051181 | |
80 | Ubiquitination | MKEGENNKPREKSES HHCCCCCCCCCHHHH | 57.97 | - | |
84 | Sumoylation | ENNKPREKSESNKRK CCCCCCCHHHHHHHH | 61.88 | - | |
85 | Phosphorylation | NNKPREKSESNKRKS CCCCCCHHHHHHHHH | 41.31 | 29214152 | |
91 | Methylation | KSESNKRKSNFSNSA HHHHHHHHHCCCCCH | 51.89 | - | |
91 | Sumoylation | KSESNKRKSNFSNSA HHHHHHHHHCCCCCH | 51.89 | 28112733 | |
91 | Ubiquitination | KSESNKRKSNFSNSA HHHHHHHHHCCCCCH | 51.89 | 21906983 | |
91 | Acetylation | KSESNKRKSNFSNSA HHHHHHHHHCCCCCH | 51.89 | 26051181 | |
92 | Phosphorylation | SESNKRKSNFSNSAD HHHHHHHHCCCCCHH | 47.33 | 29255136 | |
95 | Phosphorylation | NKRKSNFSNSADDIK HHHHHCCCCCHHHHH | 33.84 | 30266825 | |
97 | Phosphorylation | RKSNFSNSADDIKSK HHHCCCCCHHHHHHH | 31.70 | 23927012 | |
102 | Acetylation | SNSADDIKSKKKREQ CCCHHHHHHHHHHHH | 64.32 | 25953088 | |
102 | Sumoylation | SNSADDIKSKKKREQ CCCHHHHHHHHHHHH | 64.32 | 28112733 | |
102 | 2-Hydroxyisobutyrylation | SNSADDIKSKKKREQ CCCHHHHHHHHHHHH | 64.32 | - | |
102 | Ubiquitination | SNSADDIKSKKKREQ CCCHHHHHHHHHHHH | 64.32 | 21906983 | |
102 | Sumoylation | SNSADDIKSKKKREQ CCCHHHHHHHHHHHH | 64.32 | - | |
103 | Phosphorylation | NSADDIKSKKKREQS CCHHHHHHHHHHHHH | 50.47 | 30622161 | |
104 | Sumoylation | SADDIKSKKKREQSN CHHHHHHHHHHHHHH | 58.26 | - | |
104 | Ubiquitination | SADDIKSKKKREQSN CHHHHHHHHHHHHHH | 58.26 | - | |
105 | Ubiquitination | ADDIKSKKKREQSND HHHHHHHHHHHHHHH | 65.24 | - | |
106 | Acetylation | DDIKSKKKREQSNDI HHHHHHHHHHHHHHH | 65.97 | 17074863 | |
106 | Sumoylation | DDIKSKKKREQSNDI HHHHHHHHHHHHHHH | 65.97 | 28112733 | |
106 | Ubiquitination | DDIKSKKKREQSNDI HHHHHHHHHHHHHHH | 65.97 | - | |
110 | Phosphorylation | SKKKREQSNDIARGF HHHHHHHHHHHHHHH | 31.55 | 25159151 | |
115 | Methylation | EQSNDIARGFERGLE HHHHHHHHHHHHCCC | 51.14 | 115479653 | |
119 | Methylation | DIARGFERGLEPEKI HHHHHHHHCCCHHHE | 53.38 | 115479645 | |
125 | Ubiquitination | ERGLEPEKIIGATDS HHCCCHHHEEEECCC | 50.79 | - | |
130 | Phosphorylation | PEKIIGATDSCGDLM HHHEEEECCCCCCEE | 24.19 | 30108239 | |
132 | Phosphorylation | KIIGATDSCGDLMFL HEEEECCCCCCEEEE | 18.69 | 28102081 | |
133 | Glutathionylation | IIGATDSCGDLMFLM EEEECCCCCCEEEEE | 5.67 | 22555962 | |
143 | Acetylation | LMFLMKWKDTDEADL EEEEEECCCCCHHHE | 45.27 | 26051181 | |
143 | Ubiquitination | LMFLMKWKDTDEADL EEEEEECCCCCHHHE | 45.27 | 21890473 | |
143 | Methylation | LMFLMKWKDTDEADL EEEEEECCCCCHHHE | 45.27 | - | |
154 | Methylation | EADLVLAKEANVKCP HHHEEEEHHHCCCCC | 53.88 | - | |
154 | Acetylation | EADLVLAKEANVKCP HHHEEEEHHHCCCCC | 53.88 | 25953088 | |
154 | Sumoylation | EADLVLAKEANVKCP HHHEEEEHHHCCCCC | 53.88 | 28112733 | |
154 | "N6,N6-dimethyllysine" | EADLVLAKEANVKCP HHHEEEEHHHCCCCC | 53.88 | - | |
154 | Ubiquitination | EADLVLAKEANVKCP HHHEEEEHHHCCCCC | 53.88 | 21890473 | |
159 | Ubiquitination | LAKEANVKCPQIVIA EEHHHCCCCCEEEEE | 39.75 | - | |
168 | Phosphorylation | PQIVIAFYEERLTWH CEEEEEEEHHHHCCC | 14.09 | 28152594 | |
177 | Phosphorylation | ERLTWHAYPEDAENK HHHCCCCCHHHHHHH | 8.35 | - | |
184 | Ubiquitination | YPEDAENKEKETAKS CHHHHHHHHHHHHCC | 62.76 | 2190698 | |
184 | Acetylation | YPEDAENKEKETAKS CHHHHHHHHHHHHCC | 62.76 | 26051181 | |
184 | Sumoylation | YPEDAENKEKETAKS CHHHHHHHHHHHHCC | 62.76 | 28112733 | |
186 | Ubiquitination | EDAENKEKETAKS-- HHHHHHHHHHHCC-- | 63.07 | - | |
188 | Phosphorylation | AENKEKETAKS---- HHHHHHHHHCC---- | 50.91 | 24732914 | |
191 | Phosphorylation | KEKETAKS------- HHHHHHCC------- | 42.88 | 24732914 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
92 | S | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | FBXW10 | Q5XX13 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | RNF123 | Q5XPI4 | PMID:23077635 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CBX5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CBX5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-12; SER-14;SER-92 AND SER-97, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-12; SER-13;SER-14 AND SER-92, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92 AND SER-97, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-8; SER-11; SER-13;SER-14; SER-92 AND SER-110, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-12; SER-13 ANDSER-14, AND MASS SPECTROMETRY. |